COMPANY PROFILE

GCP ClinPlus

Explore full profile

Full-service China clinical CRO with US subsidiary footprint

Fengtai District, ChinaFounded 2001Biotech & Life Sciences

Valuation $50–100M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About GCP ClinPlus

GCP ClinPlus Co., Ltd. is a China-headquartered full-service clinical contract research organization with more than two decades of experience supporting innovative drug and device trials. Services cover clinical operations, biometrics, site management, regulatory submissions and specialized therapeutic expertise for pharmaceutical, biotech and medical-device sponsors in China and internationally, including a US subsidiary in Cranbury, New Jersey. Company materials cite several hundred professional staff and a headquarters address in Hanwei International Zone 3, Fengtai District, Beijing, with additional China presence including Hangzhou.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2001
Headquarters: Fengtai District, China
Employees: 20
Open positions: 15
Dealroom signal: 25.5/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Aug 2025	$2.8M	$69M	Tailong Investment	↗
EARLY VC✓Equity / VC	Jul 2022	$14M	$55M	Hangzhou Jiuyue Venture Capital · Hangzhou Tigermed · Shanghai Boquan Baifei Equity Investment · Tigermed	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

GCP ClinPlus website traffic

Latest recorded traffic for GCP ClinPlus is 350 monthly website visits, up 9.4% over the last three months. GCP ClinPlus's team declined 13% over the past year.

Latest monthly visits350 3-month web change+9.4% 1-year team growth-13%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

CTABeijing, Beijing, China · Accounting · Aug 2, 2026 CRAHangzhou, Zhejiang, China · Other · Jul 19, 2026 CRAChangchun, Jilin, China · Other · Jul 5, 2026 CRAFuzhou, Fujian, China · Other · Jun 21, 2026 scraShanghai, Shanghai, China · Other · Jun 13, 2026

5 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CLCaroCure Discovery Solutions Private LimitedPreclinical drug discovery cro that uses computational chemistry and ai to develop new drugs and cosmetics	Hyderabad, India	Operational	1	$700K	—
CBContraria BiotechDevelops innovative, cost-effective therapeutic and prophylactic drugs to combat global health challenges like antibiotic resistance, emerging diseases, and pandemics	Siena, Italy	Operational
SBSynkrino BiotherapeuticsLeverages deep industry experience and technical expertise to pinpoint early-stage ventures in under-served healthcare sectors where significant ongoing support can maximize efficiencies and produce superior returns	St. Louis, United States	Operational
OBOchre BioDevelops RNA therapies for chronic liver diseases, a leading cause of death globally	Oxford, United Kingdom	Operational
BBBigHat BiosciencesProtein therapeutics company that develops an antibody design platform guided by artificial intelligence	San Carlos, United States	Operational
XIXilisDeveloping next generation technologies for precision medicine and drug discovery	Durham, United States	Operational
MAMindRank AIMindRank AI is a developer of proprietary end-to-end AI-driven drug-discovery platform (Molecule Pro™)	Hangzhou, China	Operational
RBRosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology	Bristol, United Kingdom	Operational